|
|
19-May-2012
Purpose
The NORDIC-VII multicenter phase III trial investigated the efficacy of cetuximab when...
|
|
19-May-2012
Purpose
Over recent years, patient outcomes after colon cancer resection have not improved to the...
|
|
19-May-2012
BACKGROUND: Preoperative clinical diagnosis of lymph node involvement guides treatment decisions...
|
|
19-May-2012
BACKGROUND: Lynch syndrome is a disorder caused by mismatch repair gene mutations. Mutation...
|
|
19-May-2012
BACKGROUND: Lymph node metastasis is an important indicator of oncologic outcome for patients with...
|
|
19-May-2012
BACKGROUND: Locally advanced and recurrent colorectal cancers pose a significant therapeutic...
|
|
19-May-2012
BACKGROUND: Alcohol is considered to be a cocarcinogen or a tumor promoter, and various studies...
|
|
18-May-2012
The recent paper by Scholefield and colleagues1 on the 20 year follow-up of the...
|
|
18-May-2012
Objective
Using genome-wide promoter methylation assay, B cell CLL/lymphoma 6 member B (BCL6B) was...
|
|
18-May-2012
Background
Three large randomised trials have shown that screening for colorectal cancer (CRC)...
|
|
